2 completed. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 2 | Completed 2 |
Follow HepaStem: new trials by email Literature Review of HepaStem trials Research Report on HepaStem
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Tolerability of HepaStem in Patients With Cirrhotic and Pre-cirrhotic NASH Patients HepaStem - NASH - Nonalcoholic Steatohepatitis | Phase 1 / Phase 2 | Completed | Cellaion SA | 23 | 2019-04-09 | 2020-10-14 |
| Safety Study of HepaStem for the Treatment of Urea Cycle Disorders (UCD) and Crigler-Najjar Syndrome (CN) HepaStem - Urea Cycle Disorders, Crigler Najjar Syndrome | Phase 1 / Phase 2 | Completed | Cellaion SA | 20 | 2012-03-01 | 2020-10-19 |
Crigler-Najjar Syndrome (1) · Non-alcoholic Fatty Liver Disease (1) · Urea Cycle Disorders, Inborn (1)
Cellaion SA (2)
Belgium (2) · France (2) · Bulgaria (1) · Israel (1) · Italy (1) · Spain (1) · United Kingdom (1)